Back to Intelligence Hub
DEAcritical impact AI CURATED

Navigating DEA Registration for Telehealth Providers Prescribing Controlled Substances Across State Lines

This article clarifies the complex DEA registration requirements for telehealth providers who prescribe controlled substances, particularly when crossing state lines. It addresses the implications of the Ryan Haight Act, the expiration of COVID-19 PHE waivers, and the DEA's proposed rules for prescribing controlled medications via telemedicine.

April 14, 202617 viewsSource: Drug Enforcement Administration (DEA)

Navigating DEA Registration for Telehealth Providers Prescribing Controlled Substances Across State Lines

The ability to prescribe controlled substances via telemedicine has been a cornerstone of expanded access to care, particularly following the flexibilities introduced during the COVID-19 Public Health Emergency (PHE). However, as these emergency measures have expired, healthcare providers and businesses are navigating a complex regulatory environment governed by the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 and the Drug Enforcement Administration's (DEA) efforts to establish a permanent framework for telemedicine prescribing.

The Ryan Haight Act and the In-Person Exam Requirement

The Ryan Haight Act, enacted in 2008, generally requires an in-person medical evaluation before a practitioner can prescribe controlled substances to a patient via the internet. This was a direct response to concerns about

Original Source

https://www.deadiversion.usdoj.gov/telemedicine/telemedicine_faqs.htm

This article was generated by AI based on the source above and reviewed for accuracy. Always verify critical compliance decisions with qualified legal counsel.

Affected States

all 50+DC

Affected Specialties

mental-healthpain-managementprimary-careweight-losshormone-therapyurgent-care

Need Compliance Help?

Our team can help you understand how this regulatory change affects your specific business.

Get Started

Share This Update